Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Ipamorelin is generally considered to carry fewer risks than synthetic HGH because it stimulates the body's own GH production rather than replacing it, allowing natural feedback mechanisms like somatostatin to prevent excess
Pharma is innovating to hit even more targets The latest article I saw about the work being done in this class is a study in mice looking at a quintuple agonist (5 different targets!) I almost never write about mice studies because of how preliminary they are and how unlikely a finding in mice is to ever translate into anything useful in humans, but because of the success weve already seen of this drug class as well as the way that hitting more pathways seems to increase efficacy, I thought this was research worth highlighting
In 2019 FDA raised concerns about their safety and related adverse events reported
It may cover it if prescribed for type 2 diabetes, heart disease, kidney disease, or fatty liver disease
